St. Pierre, Roodolph
Collings, Clayton K.
Samé Guerra, Daniel D. http://orcid.org/0000-0003-1128-7089
Widmer, Christian J.
Bolonduro, Olubusayo
Mashtalir, Nazar
Sankar, Akshay
Liang, Yu http://orcid.org/0000-0001-7832-5110
Bi, Wenya Linda
Gerkes, Erica H.
Ramesh, Vijaya
Qi, Jun http://orcid.org/0000-0002-1461-3356
Smith, Miriam J. http://orcid.org/0000-0002-3184-0817
Meredith, David M.
Kadoch, Cigall http://orcid.org/0000-0002-4058-5985
Funding for this research was provided by:
Pew Charitable Trusts (Pew-Stewart Award for Cancer Research)
U.S. Department of Health & Human Services | National Institutes of Health (1DP2CA195762-01, 5F31CA228441-02)
American Brain Tumor Association (N/A)
Article History
Received: 6 August 2021
Accepted: 12 April 2022
First Online: 9 June 2022
Competing interests
: C.K. is the scientific founder, Fiduciary Board of Directors member, Scientific Advisory Board member, shareholder and consultant for Foghorn Therapeutics, Inc. (Cambridge, MA). C.K. is also a member of the Scientific Advisory Boards of Nereid Therapeutics and Nested Therapeutics, and serves as a consultant for Cell Signaling Technologies. All other authors do not declare any competing interests.